US Patent Issued to Hyloris Developments on July 1 for "Intraveneous dofetilide to reduce the risk of developing AF/AFL post coronary bypass surgery" (Illinois Inventor)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,343,320, issued on July 1, was assigned to Hyloris Developments SA (Liege, Belgium).

"Intraveneous dofetilide to reduce the risk of developing AF/AFL post coronary bypass surgery" was invented by John Somberg (Lake Forest, Ill.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention involves a novel method of reducing the risk of developing atrial fibrillation (AF) and/or atrial flutter (AFL) post coronary bypass surgery (CABS) by administering, to patients who have undergone CABS, loading and maintenance doses of dofetilide intravenously followed by oral doses."

The patent was filed on Jan. 31, 2023, under Application No. 18/162,092.

*For...